A Strategy Framwork For Deciding Between Alliances Or Acquisition Of Johnson & Johnson Pharmaceutical Company (Case Study: Strategy Farmwork of Johnson & Johnson And Cipla Inc in The Production of Anti-Infectious Drugs)

Nur Aini Fitriya Ardiani Aniqoh*  -  UIN Walisongo Semarang, Indonesia

(*) Corresponding Author

Abstract:This study analyzes a strategy framwork for deciding between alliances or acquisition of Johnson & Johnson Pharmeutical Company. The general objective of this study is to determine the appropriate corporate development strategy of Johnson & Johnson to strengthening the position in the area of infectious diseasese to help the mankind to get the best anti infectious drugs with the affordable price. Infectious diseases is a second leading killer worldwide, it is consist of HIV/ AIDS, TB, Hepatitis C, etc. Infectious diseases have caused an unprecedented global health crisis. The Asia division of Johnson & Johnson plans to invest in open innovation through more research partnerships and collaborative efforts that connect the medical and academic communities to its R&D centers especially in infectious disease. The data used in this research is data result of observation, literature study and interviews with senior executives and consultants who  handle comparable decision of Johnson&Johnson. The data show that alliance is preferrable. High uncertainty within the environment is the most influencing factor to determine this choice. Due to the industry nature, many R&D collaborations in developing particular drugs are established. By defining the proper governance structure the collaboration can limit the risk of losing in the learning race and core competencies spillover while obtaining the knowledge access to the counterparty. The Strategic alliance between Johnson & Johnson and Cipla Inc can help them toughen the corporate development strategy. Because of their similarities in the production of anti-infectious drugs, they can cooperate to penetrate emerging markets and do several R&D collaborations to create a competitive advantage.

     Key Words: Strategy Framwork, Alliance and Acquisition, Anti-Infectious Drugs

  1. References
  2. About.com. (2011). Culture: Your Environment for People at Work.(http://humanresources.about.com/od/organizationalculture/a/culture.htm. Retrieved November 8, 2018).
  3. Advantage Business Media. (2009, June 12). J&J Opens R&D Center in Shanghai. (http://www.dddmag.com/news-JJ-Opens-RD-Center-in-Shanghai-061209.aspx America’s Biotechnology Research Companies. 2010. Medicines in Development for AIDS. Retrieved November 2, 2018, from Drug Discovery & Development).
  4. Answer Corporation. (2017). Cipla Limited. (http://www.answers.com/topic/cipla. Retrieved November 13, 2018).
  5. Avert. (2011). News. (http://www.avert.org/new-aids-drugs.htm. Retrieved November 5, 2018)
  6. Bloomberg. (2011). News. (http://www.bloomberg.com/news/2011-05-23/j-j-aids-pill-signals-9-billion-in-sales-to-ease-recall-woes.html. Retrieved November 2, 2018).
  7. Brackman, S., Garretsen, H., & van Marrewijk, C. (2006). Cross Border Mergers & Acquisitions: The Facts as a Guide for International Economics, CESifo Working Paper: CESifo.
  8. Cartwright, S. & Schoenberg, R. (2006). Thirty Years of Mergers and Acquisitions Research: Recent Advances and Future Opportunities. British Journal of Management, 17: 1-5.
  9. Cipla. (n.d.). Code of conduct. (http://www.cipla.com/corporateprofile/code_of_conduct.htm. Retrieved November 8, 2011).
  10. Cummings, Stevan R. Holmberg and Jeffrey L.(2009). Building Successful Strategic Alliances. Long Range Planning, 42(2):164-193.
  11. Das and Teng. (2000). A Resource-Based Theoryof Strategic Alliances. Journal of Management 2000, Vol. 26, No. 1, 31–61.
  12. Grant RM, Baden-Fuller C.(2004). A knowledge accessing theory of strategic alliances. Journal of Management Studies,41:61–84
  13. Hoffman and Schlosser. (2000). Success Factors of Strategic Alliances in Small- and Medium-sized Enterprises: An Empirical Survey. Long Range Planning.
  14. Hoffmann, W.H. & Schaper-Rinkel W. (2001). Acquire or Ally? –A strategy framework for deciding between acquisition and cooperation. Management International Review, 41: 131-159.
  15. Hospitalharma.2010. Corporate Information. Tibotec and JJ Cleared to Launch Aptivus Rival , (http://www.hospitalpharma.com/features/feature.asp?ROW_ID=847. Retrieved November,5, 2018)
  16. Investorplace.2011. News.Vertex VS Merck in Hepatitis Drug Title Fight, (http://www.investorplace.com/2011/05/vertex-vrtx-vs-merck-mrk-in-hepatitis-drug-title-fight/ Retrieved November 5, 2018)
  17. Jeffrey H. Dyer , Marriott School at Brigham Young University in Provo, Utah.(https://hbswk.hbs.edu/archive/alliance-or-acquisition Retrieved November 10,2018).
  18. Johnson&Johnson. (2018). Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches. (http://www.jnj.com/connect/news/all/johnson-and-johnson-highlights-strategies-for-growth-through-differentiated-medicines-transformational-pipeline-and-global-product-launches. Retrieved November 2, 2018)
  19. Johnson&Johnson. (2018). Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches. (http://www.jnj.com/connect/news/all/johnson-and-johnson-highlights-strategies-for-growth-through-differentiated-medicines-transformational-pipeline-and-global-product-launches. Retrieved November 2, 2018)
  20. Krishan –maggon.2011. News.Boceprevir (Victrelis™) & Telaprevir (Incivek®, Incivo® ) Hepatitis C : FDA/EMA Review & ApprovalProtease inhibitors for HCV infections. (http://knol.google.com/k/krishan-maggon/boceprevir-victrelis-telaprevir-incivek/3fy5eowy8suq3/151#. Retrieved November, 7 2018)
  21. Lieberman. M. and D. Montgomery (1988). ‘First mover advantages’, Strategic Management Journal, Summer Special Issue, 9, pp. 41-58.
  22. Margarita.(2010). Importance of Strategic Alliances in Company's Activity. British Journal of Management.
  23. Porter, M. (1980). Competitive Strategy: Techniques for Analyzing Industries and Competitors. FreePress, New York.
  24. Prescouter.2019. (https://www.prescouter.com/2019/06/pharmaceutical-rd-global-spending-trends-in-2019/. Retrieved November, 7 2018)
  25. Priscilla Wohlstetter, Joanna Smith, Courntey L. Malloy.(2005). Strategic Alliances in Action: Toward a Theory of Evolution. The Policy of Study Journals.
  26. PhRMA. (2011). Report. (http://www.phrma.org/sites/default/files/422/aids20100.pdf. Retreived November 6, 2018)
  27. PharmaVentures Ltd. (2009, July 21). Johnson & Johnson: The Fundamentals of Alliance Management. (http://www.pharmatelevision.com/Video/261-Johnson--Johnson-Rob-Wills.aspx. Retrieved November 2, 2018)
  28. Reuters. (2011). News. (http://www.reuters.com/article/2011/06/26/pharmaceuticals-rd-idUSL6E7HO1BL20110626. Retrieved November 6, 2018)
  29. Stop-Hepatitis C. (2011). News. (http://www.stop-hepatitis-c.info/what_is_hepatitis. Retrieved November 5, 2018)
  30. UNAIDS.(2011).News. UNAIDS 2011-2015 Strategy, Getting To Zero.(http:// www.unaids.org/.../unaids/.../unaidspublication/.../20101221_JC2034E. Retrieved January 20,2019)
  31. WHO. (2011). News. (http://www.who.int/mediacentre/factsheets/fs104/en/index.html. Retrieved November 5, 2018)
  32. WHO.2018.Corporate Invormation. Infectious Disease, (http://www.who.int/topics/infectous disease/en/. Retrieved November, 6 , 2018 )

Open Access Copyright (c) 2019 Journal of Digital Marketing and Halal Industry
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.